Post surgical scarps and epidermis burn
Conditions
Interventions
There will be topical application of the product (Cicatrix cream) 2 times daily for 2 months. The dose will be 0,1 ml per centimetre of surface because the product will apply locally in the form of a
Sponsors
Catalysis SL
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: Patient with lesions characteristic of the investigated illness Patients who are between newborn and 18 years old of both sexes (ID card) Signed the Informed consent
Exclusion criteria
Exclusion criteria: Patient that refer manifestations of high sensibility to the medication or to some of the. components of the product Patient that don’t want to participate in the study Patient not very cooperative Responsible family not very cooperative
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cutaneous grooves (Excellent (E): Disappearance of the lesions to the 2 months of initiate the treatment, Good (B): marked attenuation of the lesions, diminishing their evidence 50%, Regular (R): moderate Decrease of the lesions diminishing their evidence les 50%, Bad (M): That stays the clinical square without variation). Measurement time: 2 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Color of the lesions (Attenuation of the color of the lesions (Good: if there is marked attenuation of color, Regular: Discrete attenuation of the color, Bad: if patient keeps the original color). Measurement time: 2 months. Security depends of the Adverse Events (AE)(Good: without AE, Regular: There are AE but it is possible to continue the treatment, Bad: Interruption of the treatment due AE). Measurement time: 2 months. | — |
Countries
Cuba
Contacts
Public ContactEdelisa Moredo Romo
Pediatric Hospital "Juan Manuel Marquez"
Outcome results
None listed